{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:22:55Z","timestamp":1791318175785,"version":"4.3.1"},"reference-count":85,"publisher":"Informa UK Limited","issue":"12","funder":[{"name":"not funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2018,12,2]]},"DOI":"10.1080\/14787210.2018.1544891","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T05:26:49Z","timestamp":1541741209000},"page":"929-938","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":70,"title":["Update on current approaches to diagnosis and treatment of onychomycosis"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8664-7723","authenticated-orcid":false,"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Mediprobe Research Inc., London, Canada"},{"name":"Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel R.","family":"Mays","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc., London, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah G.","family":"Versteeg","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc., London, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, Canada"},{"name":"Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, Canada"},{"name":"Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK"},{"name":"Division of Dermatology, Women\u2019s College Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.09.730"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12323"},{"issue":"11","key":"CIT0003","first-page":"762","volume":"88","author":"Westerberg DP","year":"2013","journal-title":"Am Fam Physician"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13677"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2009.01107.x"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2009.12.006"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1177\/1203475417716362"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12873"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.104794"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200119100-00002"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.00851.x"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12072"},{"key":"CIT0013","unstructured":"Medical devices and clinical trial design for the treatment or improvement in the appearance of fungally-infected nails [Internet]. FDA U.S. Food and Drug Administration. 2016. Available from: https:\/\/www.fda.gov\/downloads\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/UCM431312.pdf Accessed 16 Jul 2018."},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.06.034"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.4590"},{"issue":"1","key":"CIT0016","first-page":"6","volume":"7","author":"Sergeev AY","year":"2002","journal-title":"Skin Ther Lett"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.267"},{"issue":"5","key":"CIT0018","first-page":"626","volume":"15","author":"Elewski BE","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15181"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02464.x"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13389"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09291.x"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70316-0"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03120.x"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-009-9209-5"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.02.038"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.4.1419-1427.2006"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.6.2115-2121.2001"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.40522"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1177\/1203475417733461"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.3109\/13693781003743130"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01418-06"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12471"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12097"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2013.781691"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02991.x"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13348"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v6.i8.601"},{"key":"CIT0039","unstructured":"U.S. National Library of Medicine. DRUG RECORD: ITRACONAZOLE [Internet]. Liver Tox. 2018 cited 2018 Sep 27. Available from: https:\/\/livertox.nlm.nih.gov\/Itraconazole.htm"},{"key":"CIT0040","unstructured":"Terbinafine [Internet]. National Institutes of Health. Available from: https:\/\/livertox.nlm.nih.gov\/Terbinafine.htm#top Accessed 27 Sep 2018."},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2018.1461834"},{"key":"CIT0042","unstructured":"Diflucan. Package insert (Fluconazole) tablets, 50, 100, 150, or 200 mg [Internet]. Drugs@FDA: FDA Approved Drug Products. 2011. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/019949s051lbl.pdf Accessed 27 Sep 2018."},{"key":"CIT0043","unstructured":"U.S. Food and Drug Administration. FDA drug safety communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems [Internet]. 2016 cited 2018 Sep 27. Available from: https:\/\/www.fda.gov\/drugs\/drugsafety\/ucm362415.htm"},{"key":"CIT0044","unstructured":"LAMISIL (terbinafine hydrochloride) tablets, 250 mg, for oral use [Internet]. FDA U.S. Food and Drug Administration. 2017 cited 2018 Sep 27. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/020539s029,022071s013lbl.pdf"},{"key":"CIT0045","unstructured":"SPORANOX\u00ae (itraconazole) Capsules [Internet]. FDA U.S. Food and Drug Administration. 2018 cited 2018 Sep 27. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/020083s062lbl.pdf"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1159\/000433473"},{"key":"CIT0047","author":"Gupta A","year":"2018","journal-title":"Br J Dermatol"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2015.1119781"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04584.x"},{"key":"CIT0050","unstructured":"Valeant Pharmaceuticals. JUBLIA\u00ae (efinaconazole) topical solution, 10% [Internet]. Drugs@FDA; Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/203567s000lbl.pdf Accessed 17 Sep 2018."},{"key":"CIT0051","unstructured":"Anacor Pharmaceuticals Inc. FDA approves anacor pharmaceutica.ls\u2019 KERYDIN\n                      TM\n                      (tavaborole) topical solution, 5% for the treatment of onychomycosis of the toenails [Internet]. 2014 cited 2018 May 24. Available from: http:\/\/investor.anacor.com\/releasedetail.cfm?ReleaseID=858211"},{"key":"CIT0052","author":"Gupta A","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1159\/000441569"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03164.x"},{"key":"CIT0055","author":"Gupta AK","year":"2018","journal-title":"G Ital Dermatol E Venereol Organo Uff Soc Ital Dermatol E Sifilogr"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2016.1146687"},{"issue":"10","key":"CIT0057","first-page":"1186","volume":"13","author":"Vlahovic TC","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"CIT0058","first-page":"42","volume":"9","author":"Del Rosso JQ","year":"2016","journal-title":"J Clin Aesthetic Dermatol"},{"issue":"3","key":"CIT0059","first-page":"279","volume":"15","author":"Gupta AK","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01632-18"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1329510"},{"issue":"7","key":"CIT0062","first-page":"675","volume":"14","author":"Vlahovic T","year":"2015","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"CIT0063","first-page":"34","volume":"7","author":"Zeichner JA","year":"2014","journal-title":"J Clin Aesthetic Dermatol"},{"key":"CIT0064","first-page":"187","volume-title":"Topical nail products and ungual drug delivery","author":"Debruyne D","year":"2013"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12545"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03547.x"},{"issue":"11","key":"CIT0067","first-page":"1388","volume":"13","author":"Sakamoto M","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2014.915738"},{"key":"CIT0069","first-page":"LB 13","volume-title":"Laser 2015 ASLMS conference program","author":"Lee K","year":"2015"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2015.1066479"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14212"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2016.1151856"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.12.002"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13165"},{"key":"CIT0075","doi-asserted-by":"crossref","unstructured":"Gasser J, Pagani E, Vittadello F, et al. Frequency, type and treatment of fungal pathogens in toenail onychomycosis in the central Alpine region of South Tyrol, northern Italy - a 10-year retrospective study from 2004 to 2013. Mycoses. 2016;59(12):760\u201364. Available from: http:\/\/www.wiley.com\/bw\/journal.asp?ref=0933-7407","DOI":"10.1111\/myc.12528"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.40543"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.107754"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12533"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765201520130418"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000157"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13392"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12986"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.01.008"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1159\/000017990"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.10.023"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2018.1544891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T13:05:16Z","timestamp":1597755916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2018.1544891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":85,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12,2]]}},"alternative-id":["10.1080\/14787210.2018.1544891"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2018.1544891","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}